knowledge -WSS

knowledge

author：comprehensive 2025-10-01 18:32:16 - browse：48927

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Biotech lab space demand falls sharply

explore

WSS

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Involuntary treatment for addiction doesn't work

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Lasker Awards 2023: Winners in biomedical research

leisure time

knowledge

knowledge

How one medical school became remarkably diverse

Senators: Long

Heart attack and stroke risk calculators need revising

Why police arrested suspected Gilgo Beach killer away from his house

Walensky prepares to leave CDC — and Congress — behind

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

BioMarin wins approval for gene therapy to treat hemophilia A

CDC advisers recommend seasonal use of Pfizer RSV shot

In Memoriam: Notable people who died in 2023

Can CDC director Mandy Cohen drive consensus in Washington?

explore

Federal judge rules Oregon’s tough new gun law is constitutional

Biotech stock slump in 2023: awaiting the turnaround

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

What Congress can do to address the rural doctor shortage

Blood tests recalled over risk of missed heart attack diagnosis

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

hotspot

knowledge

explore

entertainment